| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 48,104 | 58,766 | 54,592 | 54,517 | | Cost of Revenue | 40,683 | 54,319 | 49,583 | 50,651 | | | Gross Profit | 7,420 | 4,448 | 5,009 | 3,866 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,595 | 4,866 | 4,152 | 4,954 | | Non Recurring | 876 | 6,335 | 664 | 19 | | Others | 117 | 131 | 120 | 120 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,832 | (6,885) | 73 | (1,227) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (122) | (174) | (276) | (1,077) | | Earnings Before Interest And Taxes | 1,699 | (7,118) | (183) | (2,325) | | Interest Expense | 259 | 313 | 397 | 489 | | Income Before Tax | 1,439 | (7,431) | (580) | (2,814) | | Income Tax Expense | 34 | 1,406 | 183 | (23) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,393 | (8,837) | (763) | (2,791) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,405 | (8,837) | (763) | (2,791) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,405 | ($8,837) | ($763) | ($2,791) |
|
0.26% Nasdaq 
Income Statement
